HBK Investments’s Pfizer PFE Stock Holding History

HBK Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,878	Closed	-$305K	–	354
2026 Q1	$305K	Buy	+10,878	New	+$290K	﹤0.01%	309
2022 Q2	–	Sell	-37,173	Closed	-$1.89M	–	613
2022 Q1	$1.92M	Sell	37,173 -3,287	-8%	-$171K	0.01%	414
2021 Q4	$2.39M	Buy	+40,460	New	+$2M	0.01%	400
2021 Q3	–	Sell	-27,131	Closed	-$1.06M	–	859
2021 Q2	$1.06M	Buy	+27,131	New	+$1.06M	﹤0.01%	574
2019 Q4	–	Sell	-78,388	Closed	-$2.79M	–	731
2019 Q3	$2.67M	Buy	+78,388	New	+$2.85M	0.03%	365
2019 Q2	–	Sell	-833,113	Closed	-$33.1M	–	936
2019 Q1	$33.6M	Buy	+833,113	New	+$33.4M	0.34%	37
2016 Q4	–	Sell	-117,416	Closed	-$3.77M	–	845
2016 Q3	$3.77M	Buy	+117,416	New	+$3.93M	0.03%	254
2016 Q1	–	Sell	-838,703	Closed	-$25.7M	–	1082
2015 Q4	$25.7M	Buy	+838,703	New	+$26.4M	0.24%	54

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HBK Investments's PFE Position: Q2 2026 in Review

HBK Investments sold out of Pfizer (PFE) in Q2 2026, closing a stake of 10,878 shares — an estimated $305K sold.

HBK Investments first reported a position in PFE in Q4 2015 and held it in 8 quarters. The position peaked at $33.6M in Q1 2019. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

HBK Investments reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
HBK Investments sold 10,878 Pfizer shares in Q2 2026, an estimated $305K.
HBK Investments first reported a position in Pfizer in Q4 2015 and held it in 8 quarters.
HBK Investments's Pfizer position peaked at $33.6M in Q1 2019.
2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.